VistaTablet’s mobile interface offers healthcare providers and patients access to crucial sign data collected by the VitalPatch regardless of patient location, VitalConnect said.

The handheld device will safely host and transmit the vital signs measured by VitalPatch, a FDA-cleared wearable biosensor that can measure eight vital signs in real-time. The data is presented locally for the patient and to healthcare providers via the Vista Solution platform.

VistaTablet’s mobility helps timely analysis by caregivers for patients regardless of whether they are in the hospital or at home.

The Vista Solution platform enables physiological data for all patients to be easily accessible through the accompanying cloud-based application or can be viewed directly on the VistaTablet.

“As a result of increasing healthcare costs, an increasing aging population (the number of 65 and over adults is expected to double by 2060), and demonstrated improved patient outcomes with advanced remote monitoring technologies, healthcare providers are beginning to shift eligible patients toward home care programs.

“Quality care traditionally found in a hospital has not been technologically or economically possible outside hospital walls on any significant scale until now,” VitalConnect said in a statement.

With VistaTablet and Vista Solution, VitalConnect claims that it can change the paradigm, enabling at- home programs to grow to meet the rising demands of quality home care.

VitalConnect CEO and founder Nersi Nazari said: “For acute care and the aging population, home hospital programs offer an affordable solution to healthcare that works for providers and patients.

“With the implementation of VistaTablet we are able to offer an easy-to-use mobile interface for physicians and patients to simultaneously monitor vital signs in real-time, allowing patients to recover at home while still under the care of their doctor.”

VitalConnect is a provider of wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations.